WF-47-JS03
RET kinase inhibitor orally efficacious in XG but narrow TI from data mining of internal matter and opt. ACS Med. Chem. Lett. Feb. 12, 2020 Novartis (GNF), San Diego, CA
Molecules of the Month - February 2020
Molecules of the Month
- LNP023
- LMB763 (nidufexor)
- ABBV-744
- AG-881
- FT-2102 (olutasidenib)
- GS-9876 (lanraplenib)
- "compound 25"
- "compound 25"-2
- WF-47-JS03
- BMS-986260
- GNF2133